Surface-associated proteins from Staphylococcus aureus demonstrate potent bone resorbing activity

Area of Science:

• Microbiology
• Immunology
• Orthopedics

Background:

• Staphylococcus aureus infections cause significant bone destruction in conditions like osteomyelitis and infected orthopedic implants.
• The mechanisms by which S. aureus induces bone resorption have remained largely undefined.
• Previous research identified cell surface-associated proteins (SAPs) from Gram-negative bacteria as potent stimulators of bone resorption.

Purpose of the Study:

• To investigate the role of S. aureus surface-associated components in inducing bone resorption.
• To identify the specific molecules within S. aureus responsible for osteolysis.
• To elucidate the cellular and molecular pathways involved in S. aureus-mediated bone destruction.

Main Methods:

• Isolation and characterization of surface-associated components from S. aureus.
• Murine calvarial bone resorption assay to assess osteolytic activity.
• High-performance liquid chromatography (HPLC) for fractionating and purifying active components.
• Inhibition studies using indomethacin, interleukin-1 receptor antagonist, and anti-TNF antibodies.

Main Results:

• Surface-associated components from S. aureus potently stimulated bone resorption in vitro.
• The osteolytic activity was attributed to proteins, not contaminants like lipoteichoic acid or muramyl dipeptide.
• Bone resorption was inhibited by indomethacin and blocked by interleukin-1 receptor antagonist and anti-TNF antibodies.
• HPLC fractionation identified a 32-36 kD heterodimeric protein as the most potent osteolytic agent.

Conclusions:

• Specific surface-associated proteins of S. aureus are potent mediators of bone resorption.
• These proteins may contribute significantly to the bone destruction observed in S. aureus infections.
• Targeting these bacterial proteins or their downstream signaling pathways could offer therapeutic strategies for S. aureus-induced bone loss.